Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells.

2016

Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

53

References

2

Citations